Resource Library

Helpful resources to support your practice and your patients

Treatment Initiation

Treatment initiation resources

Icon of Site of Care (SOC) guide

Site of care (SOC) guide

Helpful information to consider when selecting a site of care for your patient’s TEPEZZA infusions

DOWNLOAD

Icon of Getting started on TEPEZZA video

SOC video

Provides SOCs with insights for integrating TEPEZZA into their practice
  

WATCH VIDEO

Icon of Infusion order template

Infusion order template

A customizable template for a TEPEZZA infusion order
 

DOWNLOAD

Icon of Infusion order guide

Infusion order guide

A guide designed to help you write the infusion order for TEPEZZA
 

DOWNLOAD


Payor Access

Payor access resources

Icon of HCP payor access guide

HCP payor access guide

Interactive tool to outline the approval process, benefits investigation, letter of medical necessity, prior authorization, and appeals best practices

DOWNLOAD

Icon of Letter of medical necessity template

Letter of medical necessity template

A customizable letter of medical necessity template to support Prior Authorization (PA) for TEPEZZA
 

DOWNLOAD

Icon of Payor appeal letter template

Payor appeal letter template

A customizable appeals template for patient cases that were denied PA
 

DOWNLOAD

Icon of Site of care payor access guide

Site of care payor access guide

Key considerations for patient access, coordinating care with the prescribing office, and reimbursement

DOWNLOAD

Icon of Clinical Documentation Tearpad

Clinical Documentation Tearpad

This form outlines the Clinical Activity Score (CAS) that is used to evaluate the inflammatory signs and symptoms of TED

DOWNLOAD


Billing and Coding

Billing and coding resources

Icon of Product fact sheet

Product fact sheet

Product information, including NDC, packaging, storage, handling, and authorized distributor list

DOWNLOAD

Icon of Acquisition overview

Acquisition overview

A guide to TEPEZZA specialty distributors, specialty pharmacies, and ordering

DOWNLOAD

Icon of Coding at a glance PDF

Coding at a glance

A guide to necessary codes for billing and reimbursement, with J-code
 

DOWNLOAD

Icon of Billing and coding guide

Billing and coding guide

A guide to billing procedures, necessary codes, and reimbursement, with J-code
 

DOWNLOAD


Infusion

Infusion resources

Icon of infusion guide

Infusion guide

A detailed guide to preparing, administering, and infusing TEPEZZA

DOWNLOAD

Icon of Infusion administration video

Infusion administration video

Key steps required for reconstitution, dilution, and administration of TEPEZZA

WATCH VIDEO

Icon of Dosing calculations flashcard

Dosing calculations flashcard

A table with precalculated dosing and infusion values for patients weighing 50 kg to 120 kg (110 lb to 265 lb)

DOWNLOAD

Icon of Infusion checklist

Infusion checklist

A step-by-step checklist for the infusion process
 

DOWNLOAD

Icon of Home infusions FAQ

Home infusion FAQs

Answers to common questions about home infusion for TEPEZZA
 

DOWNLOAD
Icon of Home infusion brochure

Home infusion brochure

Considerations for choosing home infusion for TEPEZZA
 

DOWNLOAD


Patient Education

Patient education resources

Icon of TEPEZZA patient education brochure

TEPEZZA patient education brochure

An educational brochure for prospective patients to learn more about TEPEZZA
 

DOWNLOAD

Icon of Getting started on TEPEZZA

Getting started on TEPEZZA

A brochure to guide your patients through the initial steps of getting started on TEPEZZA

DOWNLOAD

Icon of Getting started on TEPEZZA video

Getting started on TEPEZZA video

A video to help your patients understand how to get started on TEPEZZA
 

WATCH VIDEO

Icon of Patient home infusion brochure

Patient home infusion brochure

A brochure that addresses patients' frequently asked questions about home infusion

DOWNLOAD

INDICATION

TEPEZZA is indicated for the treatment of Thyroid Eye Disease.

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Infusion Reactions: TEPEZZA may cause infusion reactions. Infusion reactions have been reported in approximately 4% of patients treated with TEPEZZA. Reported infusion reactions have usually been mild or moderate in severity. Signs and symptoms may include transient increases in blood pressure, feeling hot, tachycardia, dyspnea, headache, and muscular pain. Infusion reactions may occur during an infusion or within 1.5 hours after an infusion. In patients who experience an infusion reaction, consideration should be given to premedicating with an antihistamine, antipyretic, or corticosteroid and/or administering all subsequent infusions at a slower infusion rate.

Preexisting Inflammatory Bowel Disease: TEPEZZA may cause an exacerbation of preexisting inflammatory bowel disease (IBD). Monitor patients with IBD for flare of disease. If IBD exacerbation is suspected, consider discontinuation of TEPEZZA.

Hyperglycemia: Increased blood glucose or hyperglycemia may occur in patients treated with TEPEZZA. In clinical trials, 10% of patients (two-thirds of whom had preexisting diabetes or impaired glucose tolerance) experienced hyperglycemia. Hyperglycemic events should be managed with medications for glycemic control, if necessary. Monitor patients for elevated blood glucose and symptoms of hyperglycemia while on treatment with TEPEZZA. Patients with preexisting diabetes should be under appropriate glycemic control before receiving TEPEZZA.

Adverse Reactions

The most common adverse reactions (incidence ≥5% and greater than placebo) are muscle spasm, nausea, alopecia, diarrhea, fatigue, hyperglycemia, hearing impairment, dysgeusia, headache, dry skin, and menstrual disorders.

Please see Full Prescribing Information for more information.

INDICATION

TEPEZZA is indicated for the treatment of Thyroid Eye Disease.

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Infusion Reactions: TEPEZZA may cause infusion reactions. Infusion reactions have been reported in approximately 4% of patients treated with TEPEZZA. Reported infusion reactions have usually been mild or moderate in severity. Signs and symptoms may include transient increases in blood pressure, feeling hot, tachycardia, dyspnea, headache, and muscular pain. Infusion reactions may occur during an infusion or within 1.5 hours after an infusion. In patients who experience an infusion reaction, consideration should be given to premedicating with an antihistamine, antipyretic, or corticosteroid and/or administering all subsequent infusions at a slower infusion rate.

Preexisting Inflammatory Bowel Disease: TEPEZZA may cause an exacerbation of preexisting inflammatory bowel disease (IBD). Monitor patients with IBD for flare of disease. If IBD exacerbation is suspected, consider discontinuation of TEPEZZA.

Hyperglycemia: Increased blood glucose or hyperglycemia may occur in patients treated with TEPEZZA. In clinical trials, 10% of patients (two-thirds of whom had preexisting diabetes or impaired glucose tolerance) experienced hyperglycemia. Hyperglycemic events should be managed with medications for glycemic control, if necessary. Monitor patients for elevated blood glucose and symptoms of hyperglycemia while on treatment with TEPEZZA. Patients with preexisting diabetes should be under appropriate glycemic control before receiving TEPEZZA.

Adverse Reactions

The most common adverse reactions (incidence ≥5% and greater than placebo) are muscle spasm, nausea, alopecia, diarrhea, fatigue, hyperglycemia, hearing impairment, dysgeusia, headache, dry skin, and menstrual disorders.

Please see Full Prescribing Information for more information.